CAPPS VICKIE L

Vickie L Capps — a longtime healthcare-device executive whose most prominent public-company role was at DJO Inc (formerly DJ Orthopedics) during the mid-2000s — carries a 281-transaction Form 4 register whose live signal is defined by a disciplined, sell-free accumulation pattern in two small-cap healthcare names: Janux Therapeutics (JANX) and Orthofix Medical (OFIX). Capps has acquired JANX shares through ten separate Form 4 filings since June 2022 — a consistent drip of RSU-vesting and open-market-acquisition events totaling approximately 45,000 shares at prices between $8 and $14, with the most recent acquisition on June 11, 2026 at $13.66 per share — without a single corresponding sale in the register. At Orthofix, the pattern is analogous: two large acquisitions in March 2025 (35,270 shares at $17.10 and 3,093 shares) followed by another 14,965-share acquisition in June 2026, again with no disposition activity. The register's older chapters — DJO selling during the 2004–2007 executive-compensation window (342,363 shares sold), NuVasive's gradual run-off through 2023, and a one-time Amedisys dividend-reinvestment event — belong to a prior chapter. The live read is a healthcare insider who has concentrated her residual accumulation into two small-cap clinical-stage names, both of which trade in the orthopedic-spine-and-protein-binding therapeutic space, and who has not trimmed either position despite multi-year holding periods.